A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity

NCT03842202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Semaglutide
DRUG: Placebo

Sponsor

Novo Nordisk A/S